{"id":"CHEMBL1076637","canonicalSmiles":"N[C@H](Cc1ccc(O)cc1)C(=O)O","inchiKey":"OUYCCCASQSFEME-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-Tyrosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Tyrosine"],"crossReferences":{"PubChem":["26754407","26754408"],"drugbank":["DB03839"],"chEBI":["28479"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1080983","canonicalSmiles":"COCC(=O)Nc1cc(Sc2ccccc2)ccc1N/C(=N\\C(=O)OC)NC(=O)OC","inchiKey":"HMCCXLBXIJMERM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEBANTEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Combotel","Negabot plus paste","Oratel","Rintal"],"synonyms":["BAY H 5757","BAY VH 5757","BAY-H-5757","BAY-VH-5757","BAYH-5757","BAYVH-5757","Febantel","Febantel for veterinary use"],"crossReferences":{"PubChem":["144206335","50125904"],"drugbank":["DB11409"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL108821","canonicalSmiles":"N[C@@H]1CN(c2c(F)cc3c(=O)c(C(=O)O)cn([C@@H]4C[C@@H]4F)c3c2Cl)CC12CC2","inchiKey":"PNUZDKCDAWUEGK-CYZMBNFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITAFLOXACIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Sitafloxacin"],"chEBI":["4304"]},"childChemblIds":["CHEMBL3989504"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1169490","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)S2)c(=O)n1","inchiKey":"MOMUJZRKXYLWMH-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4'-THIO-2'-DEOXYCYTIDINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-deoxy-4'-thiocytidine","4'-thio-2'-deoxycytidine","4'-thio-2'-deoxycytidine, (-)-","NSC-764276","Tdcyd"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1200406","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O","inchiKey":"NFLLKCVHYJRNRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMENHYDRINATE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antemin","Dimenhydrinate","Dramamine","Vertigo-vomex s"],"synonyms":["Chloranautine","Dimenhydrinate","NSC-117855"],"crossReferences":{"DailyMed":["dimenhydrinate"],"DrugCentral":["901"],"PubChem":["11112942","144207521","17389041","26747407"],"Wikipedia":["Dimenhydrinate"],"drugbank":["DB00985"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_1001463","HP_0002321","EFO_0004888","HP_0002013","MONDO_0004900","EFO_0003843","HP_0002018"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for vomiting and has 2 investigational indications."}
{"id":"CHEMBL1200570","canonicalSmiles":"CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"MBBZMMPHUWSWHV-BDVNFPICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEGLUMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["D(-)-n-methylglucamine","Meglumine","Megluminum","Methylglucamine","N-methylglucamine","N-methylsorbitylamine","NSC-52907","NSC-7391"],"crossReferences":{"PubChem":["144205883","144212354","170465359"],"chEBI":["59732"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1200939","canonicalSmiles":"Cl.N","inchiKey":"NLXLAEXVIDQMFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ammonium chloride","Chlorammonic","Tussi ammon co"],"synonyms":["Ammonium chloride","Ammonium chloride ((nh4)cl)","Ammonium muriate","Ammonium muriaticum","Amoklor","Catalyst rd","Darammon","E 510","E-510","E510","FEMA NO. 4494","Ins no.510","Ins-510","Sal ammoniac","Salammoniacus"],"crossReferences":{"DrugCentral":["4350"],"drugbank":["DB06767"],"chEBI":["31206"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200940","canonicalSmiles":"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl.O","inchiKey":"KJBLQGHJOCAOJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METOCLOPRAMIDE HYDROCHLORIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL86","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["\"clopra-\"\"yellow\"\"\"","Clopra","Clopra-\"Yellow\"","Gastrese l.a.","Gastrobid continus","Gastroflux","Gastromax","Gimoti","Maxolon","Maxolon sr","Metoclomex","Metoclopramide hydrochloride","Metoclopramide intensol","Metox","Metozolv odt","Metramid","Mygdalon","Parmid","Primperan","Reglan","Reglan odt"],"synonyms":["AHR-3070-C","Metipamid","Metoclopramide dihydrochloride monohydrate","Metoclopramide hcl monohydrate","Metoclopramide hydrochloride","Metoclopramide hydrochloride monohydrate","Metoclopramide monohydrochloride monohydrate","Metoclopramidi hydrochloridum","NSC-757117"],"crossReferences":{"DailyMed":["metoclopramide%20hydrochloride"],"chEBI":["6899"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000164270","ENSG00000166736"],"count":3},"linkedDiseases":{"rows":["EFO_1001463","HP_0002039","HP_0002017","EFO_0004888","HP_0002013","EFO_0005611","EFO_1000948","EFO_1002048","EFO_0000311","HP_0002018"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 7 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201117","canonicalSmiles":"COc1ccccc1OCC(O)COC(N)=O","inchiKey":"GNXFOGHNGIVQEH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOCARBAMOL","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Delaxin","Forbaxin","Methocarbamol","Miolaxin","Neuraxin","Robaxin","Robaxin-750"],"synonyms":["Methocarbamol","NSC-170960"],"crossReferences":{"DailyMed":["methocarbamol"],"PubChem":["144204005","170464808","174006834","26747217","26747218","56422407","855587"],"Wikipedia":["Methocarbamol"],"drugbank":["DB00423"],"chEBI":["77498"]},"linkedTargets":{"rows":["ENSG00000133742"],"count":1},"linkedDiseases":{"rows":["EFO_0001422","EFO_0003931","HP_0003419","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 2 investigational indications."}
{"id":"CHEMBL1201387","canonicalSmiles":"C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21","inchiKey":"AHYHTSYNOHNUSH-HXFGRODQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANDOLAPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RU-44403","Trandolapril diacid","Trandolapril related compound e","Trandolaprilat"],"crossReferences":{"drugbank":["DB14209"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201520","drugType":"Unknown","blackBoxWarning":false,"name":"UROFOLLITROPIN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bravelle","Fertinex","Fostimon","Gonadotraphon fsh","Metrodin","Metrodin high purity","Orgafol","Urofollitrophin"],"synonyms":["Fertinorm","Follitropin human","Urofollitrophin","Urofollitropin"],"crossReferences":{"Wikipedia":["Urofollitropin"]},"linkedTargets":{"rows":["ENSG00000170820"],"count":1},"linkedDiseases":{"rows":["EFO_0004248","EFO_0000545","EFO_0000279","EFO_0008560","MONDO_0002775"],"count":5},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 5 investigational indications."}
{"id":"CHEMBL1201622","drugType":"Unknown","blackBoxWarning":false,"name":"PORACTANT ALFA","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Curosurf"],"synonyms":["CHF-6440 COMPONENT PORACTANT ALFA","Poractant Alfa","Poractant alfa"],"crossReferences":{"DailyMed":["poractant%20alfa"],"DrugCentral":["5148"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL1231708","canonicalSmiles":"C[C@](O)(CO)[C@H](O)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O","inchiKey":"YFAUKWZNPVBCFF-XHIBXCGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231708","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03687"],"chEBI":["16578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236620","canonicalSmiles":"CCOC(=O)c1c(/C(C#N)=C\\N)c2ccc(Cl)c(Cl)c2n1C","inchiKey":"CXJCGSPAPOTTSF-VURMDHGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236620","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08691"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12760","canonicalSmiles":"Cn1cc(C(=O)Cc2ccccc2)cc1/C=C/C(=O)NO","inchiKey":"UFQOXIMRSMFQRI-BQYQJAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL12760","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07350"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1314751","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"DSKIOWHQLUWFLG-SPIKMXEPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCHLORPERAZINE MALEATE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL728","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Buccastem","Buccastem m","Compazine","Prochlorperazine maleate","Procomp","Proziere","Vertigon"],"synonyms":["Prochlorperazine dimaleate","Prochlorperazine maleate"],"crossReferences":{"DailyMed":["prochlorperazine%20maleate"],"PubChem":["144207071","170464761","50106935"],"chEBI":["8436"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1412041","canonicalSmiles":"C[C@H](N)[C@@H](O)c1ccccc1","inchiKey":"DLNKOYKMWOXYQA-IONNQARKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CATHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(1s,2s)-pseudonorephedrine","Cathine","Cathinum","Norpseudoephedrine","Norpseudoephedrine, d-","Phenylpropanolamine d-threo-form"],"crossReferences":{"PubChem":["11112311"],"drugbank":["DB01486"],"chEBI":["4109"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1444","canonicalSmiles":"N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1","inchiKey":"HPJKCIUCZWXJDR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETROZOLE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Femara","Letrozole"],"synonyms":["CGS 20267","CGS-20267","Letrozole","NSC-759652"],"crossReferences":{"DailyMed":["letrozole"],"PubChem":["11112889","124882709","144204270","144213877"],"Wikipedia":["Letrozole"],"drugbank":["DB01006"],"chEBI":["6413"]},"linkedTargets":{"rows":["ENSG00000137869"],"count":1},"linkedDiseases":{"rows":["EFO_1000256","EFO_0003869","Orphanet_64739","EFO_0001075","EFO_0003859","MONDO_0003061","EFO_0005952","EFO_1000984","EFO_0000588","EFO_0000564","EFO_1000251","MONDO_0016784","MONDO_0002715","EFO_0001416","Orphanet_145","MONDO_0004658","MONDO_0008170","EFO_1001512","MONDO_0002775","EFO_0000660","Orphanet_418","EFO_0009708","EFO_0000553","EFO_0000731","EFO_0005537","EFO_0000432","EFO_0003922","EFO_1001346","EFO_0001065","MONDO_0015686","MONDO_0007254","EFO_0004230","Orphanet_538","MONDO_0002087","EFO_0003882","EFO_0000305","MONDO_0018555","EFO_0002950","MONDO_0002158","EFO_0003968","EFO_0000279","EFO_0008509","EFO_0000616","EFO_0000186","EFO_0000545","EFO_1001757","EFO_0000313","HP_0031456","EFO_0001073","EFO_0003060","HP_0004322","EFO_0000304","MONDO_0011962","HP_0001510","MONDO_0024880","EFO_0003833","EFO_1000233"],"count":57},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 4 approved and 38 investigational indications."}
{"id":"CHEMBL1454","canonicalSmiles":"c1ccc([C@H]2CN3CCSC3=N2)cc1","inchiKey":"HLFSDGLLUJUHTE-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVAMISOLE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Levamisole","TCMDC-125847","Tetramisole, (s)-"],"crossReferences":{"PubChem":["90341409"],"Wikipedia":["Levamisole"],"drugbank":["DB00848"],"chEBI":["6432"]},"childChemblIds":["CHEMBL1770"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for helminthiasis and has 6 investigational indications."}
{"id":"CHEMBL148756","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)O)c(C)n2Cc1ccccc1","inchiKey":"ZEKCBTQHDTUHRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL148756","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03121"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL153983","canonicalSmiles":"CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCCOC(=O)c1cccnc1","inchiKey":"AYJVGKWCGIYEAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RONIFIBRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ronifibrate"],"crossReferences":{"Wikipedia":["Ronifibrate"],"drugbank":["DB13460"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1599","canonicalSmiles":"CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1","inchiKey":"UQLLWWBDSUHNEB-CZUORRHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHAPIRIN","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefapirin","Cephapirin"],"crossReferences":{"Wikipedia":["Cefapirin"],"drugbank":["DB01139"],"chEBI":["554446"]},"childChemblIds":["CHEMBL1201043","CHEMBL3989837"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and is indicated for bacterial disease."}
{"id":"CHEMBL165024","canonicalSmiles":"Cc1cc(CCCCCOc2ccc(C3=N[C@@H](C)CO3)cc2)on1","inchiKey":"UXIYKMARWUSIKU-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL165024","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08724"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL166","canonicalSmiles":"Nc1nc(N)nc(Nc2ccc([As]3SCC(CO)S3)cc2)n1","inchiKey":"JCYZMTMYPZHVBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELARSOPROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mel b","Melarsoprol","RP 3854","RP-3854"],"crossReferences":{"Wikipedia":["Melarsoprol"],"drugbank":["DB12864"],"chEBI":["6729"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1684984","canonicalSmiles":"CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21","inchiKey":"JEGHXKRHKHPBJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PA-799","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CH-5132799","CH5132799","Ch 5132799","PA-799","PA799","Pa-799"],"crossReferences":{"drugbank":["DB13051"]},"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1697733","canonicalSmiles":"CC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C","inchiKey":"RDHQFKQIGNGIED-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLCARNITINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nicetile"],"synonyms":["Acetyl carnitine hcl","Acetyl-L-Carnitine","Acetyl-l-carnitine","Acetylcarnitine","Branigen","Levacecarnine hydrochloride","NSC-747431","Normobren","Oristar ach","ST-200","Zibren"],"crossReferences":{"Wikipedia":["Acetylcarnitine"],"drugbank":["DB08842"],"chEBI":["57589"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for attention deficit hyperactivity disorder and has 8 investigational indications."}
{"id":"CHEMBL1697844","canonicalSmiles":"O=C(OC[C@H]1O[C@](O)(COC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@@H]1OC(=O)c1cccnc1)c1cccnc1","inchiKey":"FUWFSXZKBMCSKF-ZASNTINBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOFURANOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bradilan"],"synonyms":["ES 304","ES-304","Nicofuranose"],"crossReferences":{"PubChem":["144205184"],"drugbank":["DB13422"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1742991","drugType":"Antibody","blackBoxWarning":false,"name":"BENRALIZUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fasenra"],"synonyms":["BIW-8405","Benralizumab","MEDI-563"],"crossReferences":{"DailyMed":["benralizumab"]},"linkedTargets":{"rows":["ENSG00000091181"],"count":1},"linkedDiseases":{"rows":["EFO_0004232","EFO_0007187","HP_0006536","EFO_0005531","EFO_0007486","EFO_1000391","HP_0001871","MONDO_0004979","EFO_0000341","EFO_0000274","EFO_1001467","HP_0002110"],"count":12},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for asthma and airway obstruction and has 9 investigational indications."}
{"id":"CHEMBL1743008","drugType":"Antibody","blackBoxWarning":false,"name":"DROZITUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-DR5","ANTI-DR5 RHUMAB-DR5","Drozitumab","PRO-95780","RHUMAB DR5","RHUMAB-DR5","Usp mab 003, monoclonal igg1"],"linkedTargets":{"rows":["ENSG00000120889"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_0005952","EFO_0003060","EFO_0000333","EFO_1001951"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743203","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC=C4CC(=O)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"SQGZFRITSMYKRH-QAGGRKNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"delta5-ADD","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["delta5-ADD"],"crossReferences":{"drugbank":["DB01456"],"chEBI":["83865"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1744447","canonicalSmiles":"CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2]","inchiKey":"LALFOYNTGMUKGG-BGRFNVSISA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSUVASTATIN CALCIUM","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1496","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crestor","Ezallor","Ezallor sprinkle","Rosuvastatin calcium"],"synonyms":["Fortius","NSC-747274","NSC-758930","Rostar","Rosuvastatin (as calcium)","Rosuvastatin calcium","Rosuvastatin calcium salt","Rosuvastatin hemicalcium","Rozavel","S-4522","Suvikan","ZD-4522","ZD-4522 (CALCIUM SALT)","ZD-4522 CALCIUM","ZD4522 (CALCIUM SALT)","ZD4522 CALCIUM"],"crossReferences":{"DailyMed":["rosuvastatin%20calcium"],"chEBI":["77249"]},"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["HP_0002140","HP_0003124","EFO_0001645","EFO_1001461","EFO_0004911","Orphanet_309005","EFO_0000537","EFO_0004239","EFO_0003914","EFO_0004211","MONDO_0021187","Orphanet_412","EFO_0003144","MONDO_0005147","Orphanet_79211","MONDO_0005148","EFO_0003918","EFO_0000400","EFO_0005672","EFO_0009878"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 6 approved and 10 investigational indications."}
{"id":"CHEMBL1766","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO","inchiKey":"VWVSBHGCDBMOOT-IIEHVVJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESOXIMETASONE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desoximetasone","Stiedex","Stiedex lp","Stiedex lpn","Topicort","Topicort lp"],"synonyms":["A-41-304","A-41304","Desoximetasone","Desoxymethasone","HOE 304","HOE-304","J83.644C","NSC-759189","R 2113","R-2113"],"crossReferences":{"DailyMed":["desoximetasone"],"PubChem":["144204440","170464795","29215017","56423147","855924"],"Wikipedia":["Desoximetasone"],"drugbank":["DB00547"],"chEBI":["691037"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001494","EFO_0000701","EFO_0000676","EFO_0000274"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 3 approved indications."}
{"id":"CHEMBL17962","canonicalSmiles":"N[C@@H](Cc1c[nH]cn1)C(=O)O","inchiKey":"HNDVDQJCIGZPNO-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HISTIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3694","Histidine","L-histidine","NSC-137773"],"crossReferences":{"PubChem":["11111281","90340851"],"Wikipedia":["Histidine"],"drugbank":["DB00117"],"chEBI":["15971"]},"childChemblIds":["CHEMBL1256578"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL180792","canonicalSmiles":"C[C@H](COc1ccc([C@@H]2Oc3ccc(O)cc3S[C@@H]2c2ccc(O)cc2)cc1)N1CCCC1","inchiKey":"UZOOIPXOYYJULJ-BLIZRMSTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL180792","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02615"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1893913","canonicalSmiles":"CCCCNC(=O)OCC#CI","inchiKey":"WYVVKGNFXHOCQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOCARB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iodocarb"],"crossReferences":{"PubChem":["144209062","144211434","26757795"],"drugbank":["DB15666"],"chEBI":["83279"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1909289","canonicalSmiles":"CCOC(Nc1ccc(C(=O)O)cc1)C(=O)c1ccc(-c2ccccc2)cc1","inchiKey":"BPOMPTVRBWXZBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XENAZOIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Francia"],"classes":["Hepatotoxicity"],"year":1965},"tradeNames":[],"synonyms":["CV 58903","CV-58903","NSC-43842","NSC-58991","NSC-59182","SKF-8318","Xanalamine","Xenalamine","Xenazoic acid","Xenovis"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Francia  in 1965 due to Hepatotoxicity."}
{"id":"CHEMBL196","canonicalSmiles":"O=C1O[C@H]([C@@H](O)CO)C(O)=C1O","inchiKey":"CIWBSHSKHKDKBQ-JLAZNSOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASCORBIC ACID","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ascor","Ascorbicap","Ascur","Bassett's","Cebione","Cecon","Cenolate","Cetane","Cetane-caps tc","Cevalin","Cevex","Haliborange","Redoxon","Redoxon c","Redoxon chew-c","Redoxon slow release","Top c","Vital life","Vitamin C"],"synonyms":["3-keto-l-gulofuranolactone","Acidum ascorbicum","Ascoltin","Ascorbate","Ascorbic Acid","Ascorbic acid","Ascorbic acid (vit c)","Ascorbic acid, l-","Ascorbicum acidum","Cevitamic acid","E-300","E300","FEMA NO. 2109","INS NO.300","INS-300","L-ascorbate","L-ascorbic acid","NSC-218455","NSC-33832","Vitamin c","Vitamin c (as ascorbic acid)"],"crossReferences":{"DailyMed":["ascorbic%20acid"],"PubChem":["144203866","144205657","144209325","144213275","170464728","17390038","26757776"],"Wikipedia":["Ascorbic_acid","Vitamin_C"],"drugbank":["DB00126"],"chEBI":["29073"]},"childChemblIds":["CHEMBL3350399"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 6 approved and 90 investigational indications."}
{"id":"CHEMBL2095209","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)OCC","inchiKey":"SSQPWTVBQMWLSZ-AAQCHOMXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICOSAPENT ETHYL","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vascepa"],"synonyms":["AMR 101","AMR-101","AMR101","Eicosapentaenoic acid ethyl ester","Epadel","Ethyl icosapent","Ethyl icosapentate","Icosapent ethyl","Icosapent ethyl ester","NSC-759597","Timnodonic acid ethyl ester"],"crossReferences":{"DailyMed":["icosapent%20ethyl"],"drugbank":["DB08887"],"chEBI":["80366"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for pancreatitis and hypertriglyceridemia and has 6 investigational indications."}
{"id":"CHEMBL2105391","canonicalSmiles":"CCCOC(=O)c1sc(C(=O)OCCC)c(O)c1O","inchiKey":"GUFHWUFYAOUKTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTIOFATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Protiofate"],"crossReferences":{"drugbank":["DB13632"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106489","canonicalSmiles":"[15OH2]","inchiKey":"XLYOFNOQVPJJNP-BJUDXGSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WATER O 15","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1098659","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["15o","Water o 15"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108299","drugType":"Unknown","blackBoxWarning":false,"name":"METFORMIN GLYCINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DMMET-01","Metformin glycinate"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108655","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLEVAMER POTASSIUM SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GT-267-004","GT-267004","GT267-004","Tolevamer potassium sodium"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109248","drugType":"Antibody","blackBoxWarning":false,"name":"APOMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Apomab"],"synonyms":[],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109326","drugType":"Antibody","blackBoxWarning":false,"name":"MIK-BETA-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MIK-BETA-1","Mik-beta-1"],"linkedTargets":{"rows":["ENSG00000100385"],"count":1},"linkedDiseases":{"rows":["EFO_0000565"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109558","drugType":"Antibody","blackBoxWarning":false,"name":"MU-J591","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MU-J591","Mu-j591"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110809","canonicalSmiles":"CCCCSc1ccc(C(SCCN(C)C)c2ccccc2)cc1","inchiKey":"IZLPZXSZLLELBJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPTODIAME","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Captodiame","Captodiamine"],"crossReferences":{"drugbank":["DB09014"]},"childChemblIds":["CHEMBL2106143"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111030","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2cccnc21","inchiKey":"JTTAUPUMOLRVRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTHIPENDYL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Prothipendyl"],"crossReferences":{"drugbank":["DB12958"]},"childChemblIds":["CHEMBL2107124"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL2364603","canonicalSmiles":"COc1c(N2CCC/C(=C(\\F)CN)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12.Cl","inchiKey":"RDXCNSOGHLLWDV-YFMOEUEHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACORAFLOXACIN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1257096","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acorafloxacin hydrochloride","Avarofloxacin hydrochloride","JNJ-32729463-AAC","JNJ-32729463AAC","Jnj-32729463","Jnj-q2 hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2364968","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12","inchiKey":"ZQLJWTRXKINMIN-BEJKIDSHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGOLOID","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["ergoloid%20mesylates"]},"childChemblIds":["CHEMBL2311030"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000135312","ENSG00000184160","ENSG00000178394","ENSG00000184845","ENSG00000149295","ENSG00000069696","ENSG00000151577","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000169676","ENSG00000150594"],"count":13},"linkedDiseases":{"rows":["EFO_0004718","EFO_0000319","Orphanet_908"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL252642","canonicalSmiles":"O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)ccc21","inchiKey":"FURUXTVZLHCCNA-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIQUIRTIGENIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2S)-Liquiritigenin","4',7-Dihydroxyflavanone","7,4'-Dihydroxyflavanone","Liquiritigenin","Liquirtigenin"],"crossReferences":{"drugbank":["DB03601"],"chEBI":["28777"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL262747","canonicalSmiles":"CC(=O)Nc1ccc(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](Cc2cccnc2)NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(C)=O)C(=O)N[C@H](Cc2ccc(NC(C)=O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)cc1","inchiKey":"ZWNUQDJANZGVFO-YHSALVGYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ACYLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acyline","MER-104"],"crossReferences":{"drugbank":["DB11906"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL276520","canonicalSmiles":"c1ccc2c(CCC3CCNCC3)c[nH]c2c1","inchiKey":"SADQVAVFGNTEOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDALPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hematological toxicity"],"year":1985},"tradeNames":[],"synonyms":["Indalpine","LM-5008"],"crossReferences":{"Wikipedia":["Indalpine"],"drugbank":["DB08953"]},"childChemblIds":["CHEMBL2362557"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1985 due to Hematological toxicity."}
{"id":"CHEMBL3039518","canonicalSmiles":"COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12","inchiKey":"URWYQGVSPQJGGB-DHUJRADRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BATEFENTEROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Batefenterol","GSK-961081A","GSK961081","GSK961081A","TD-5959"],"crossReferences":{"drugbank":["DB12526"]},"childChemblIds":["CHEMBL3039512"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000133019","ENSG00000181072"],"count":3},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL32190","canonicalSmiles":"COc1cc(CN(C)c2cnc3nc(N)nc(N)c3c2)cc(OC)c1OC","inchiKey":"PUOZHLHNKHRTOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL32190","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02919"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3246831","canonicalSmiles":"Cc1nnc2n1-c1ccc(Br)cc1C(c1ccccn1)=NC2","inchiKey":"BGRWSFIQQPVEML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3246831","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14718"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL340807","canonicalSmiles":"COc1ccc2c3c([nH]c2c1)C(C)=NCC3","inchiKey":"RERZNCLIYCABFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HARMALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Harmaline"],"crossReferences":{"PubChem":["11113138","11533026","124882832","124882834","124882835","26748426","26748427","26753726","26753727","50107396","50107397","56424137"],"Wikipedia":["Harmaline"],"drugbank":["DB13875"],"chEBI":["28172"]},"childChemblIds":["CHEMBL1494278","CHEMBL2089157","CHEMBL2165708","CHEMBL326436"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL346178","canonicalSmiles":"CC(=O)N(C)C1(c2ccccc2)CCN(CCC[C@]2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)c3ccccc3)C2)CC1","inchiKey":"DZOJBGLFWINFBF-UMSFTDKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSANETANT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Osanetant","SB-236984","SR-14280","SR-142801","SR142801"],"crossReferences":{"Wikipedia":["Osanetant"],"drugbank":["DB04872"]},"childChemblIds":["CHEMBL2311148"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL354201","canonicalSmiles":"CC1=C(C)C(=O)c2ccccc2C1=O","inchiKey":"LGFDNUSAWCHVJN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,3-Dimethyl-[1,4]Naphthoquinone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3-Dimethyl-[1,4]Naphthoquinone"],"crossReferences":{"drugbank":["DB07669"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544959","drugType":"Small molecule","blackBoxWarning":false,"name":"ARRY-382","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arry-382"],"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0024880"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3544997","drugType":"Small molecule","blackBoxWarning":false,"name":"LS-104","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ls-104","Tyrene cr-4"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545083","canonicalSmiles":"COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1","inchiKey":"XLSYZSRXVVCHLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RGB-286638","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RGB 286638","Rgb-286638"],"linkedTargets":{"rows":["ENSG00000123374","ENSG00000134058","ENSG00000164885","ENSG00000135446","ENSG00000136807","ENSG00000170312"],"count":6},"linkedDiseases":{"rows":["EFO_0001642"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545368","canonicalSmiles":"CC(O)C(=O)O.Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1","inchiKey":"XVDWNSFFSMWXJJ-ASTDGNLGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PANOBINOSTAT LACTATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL483254","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Farydak"],"synonyms":["Panobinostat lactate","Panobinostat lactate anhydrous"],"crossReferences":{"DailyMed":["panobinostat%20lactate"],"chEBI":["85991"]},"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000147099","ENSG00000163517","ENSG00000100429","ENSG00000116478","ENSG00000068024","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for multiple myeloma. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545370","drugType":"Antibody","blackBoxWarning":false,"name":"EMACTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7i1955n5wx","Emactuzumab","RG-7155","RG7155","RO-5509554","RO5509554","RO5509554 (ANTI-CSF-R1)"],"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0005952","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545372","drugType":"Antibody","blackBoxWarning":false,"name":"SOFITUZUMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-MUC16 ADC","DMUC-5754A","DMUC5754A","RG-7458","Sofituzumab vedotin"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000181143","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0008170"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL358064","canonicalSmiles":"CCCCOc1ccc(S(=O)(=O)N2C[C@@H](NS(C)(=O)=O)C[C@@H]2C(=O)NO)cc1","inchiKey":"ULDXUWXTVRRUND-SWLSCSKDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL358064","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02367"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3669417","canonicalSmiles":"N#Cc1ccc2c(c1)[C@H]1CCCN(C(=O)c3ccc4[nH]cnc4c3)[C@H]1C2","inchiKey":"VVZNCSHIBODHMZ-UZLBHIALSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BI-187004","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bi 187004","Bi-187004"],"linkedTargets":{"rows":["ENSG00000117594"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL369075","canonicalSmiles":"NC(=O)c1cnc2n1CCc1ccccc1C21CCNCC1","inchiKey":"VQWGYPVNVICKFC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VAPITADINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vapitadine"],"crossReferences":{"drugbank":["DB05738"]},"childChemblIds":["CHEMBL539843","CHEMBL1203919"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3707393","canonicalSmiles":"N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1.O=P(O)(O)O","inchiKey":"FMCPYRDGUZBOJZ-BTQNPOSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSILODROSTAT PHOSPHATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3099695","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isturisa"],"synonyms":["LCI699-AZA","Osilodrostat phosphate"],"crossReferences":{"DailyMed":["osilodrostat%20phosphate"]},"linkedTargets":{"rows":["ENSG00000160882"],"count":1},"linkedDiseases":{"rows":["EFO_1001110"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for pituitary-dependent cushing's disease."}
{"id":"CHEMBL386051","canonicalSmiles":"CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1","inchiKey":"VAARYSWULJUGST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-0173955","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-0173955","PD-17395"],"crossReferences":{"drugbank":["DB02567"],"chEBI":["49791"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL388154","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](O[P@@](=O)(O)O[P@@](=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"LFTYTUAZOPRMMI-CFRASDGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL388154","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03397"],"chEBI":["16264"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3912251","canonicalSmiles":"Cc1cc(C(=O)O)ccc1COc1cc2c(cc1N(CC(C)C)S(=O)(=O)c1nccs1)CCC2","inchiKey":"ALLLQQUASFFEKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONO-8539","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONO-8539","Ono-8539"],"crossReferences":{"drugbank":["DB15325"]},"linkedTargets":{"rows":["ENSG00000160951"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_1000781"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989936","canonicalSmiles":"C[C@]12C[C@H](c3ccc(S(C)(=O)=O)cc3)C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C(F)(F)C(F)(F)F","inchiKey":"JUFWQQVHQFDUOD-ANRPBIDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VILAPRISAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1002670","BAY1002670","Vilaprisan"],"crossReferences":{"drugbank":["DB11971"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000731","EFO_0001065","MONDO_0001572"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL404155","canonicalSmiles":"O=C(Cc1cccs1)N[C@H](B(O)O)c1ccccc1","inchiKey":"LGJCDEZMANATFA-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL404155","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08552"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL417844","canonicalSmiles":"C=C=CCNCCCCNCC=C=C","inchiKey":"IKSQCMLJDHRWOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL417844","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04188"]},"childChemblIds":["CHEMBL4439012"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297422","canonicalSmiles":"CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)Nc2ccccc2-c2ccccc21","inchiKey":"OJPLJFIFUQPSJR-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-4733","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RO 4929097","RO-4929097","Rg 4733","Rg-4733","Ro4929097"],"crossReferences":{"drugbank":["DB11870"]},"linkedTargets":{"rows":["ENSG00000138613","ENSG00000205155","ENSG00000162736","ENSG00000080815","ENSG00000143801","ENSG00000117362"],"count":6},"linkedDiseases":{"rows":["EFO_0000616","EFO_0008515","EFO_0000365","EFO_0001075","MONDO_0015686","EFO_0000756","EFO_0000349","EFO_1001465","EFO_1000657","MONDO_0007254","EFO_0002501","MONDO_0021063","MONDO_0023619","EFO_0000305","EFO_0003060","MONDO_0003865","EFO_1000044","EFO_0006861","EFO_0005537","EFO_0000389","EFO_1000251","EFO_0000673","EFO_0001378","EFO_0002499"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 19 investigational indications."}
{"id":"CHEMBL4297508","canonicalSmiles":"CC(C)C[C@@H](C(=O)Nc1ccn(C[C@@H](O)CO)n1)N1CC(Oc2ccccc2Cl)=CC1=O","inchiKey":"HMUMWSORCUWQJO-QAPCUYQASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORZAGLIATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dorzagliatin","HMS-5552","HMS5552","Hms5552","RO-5305552","RO5305552","Sinogliatin"],"crossReferences":{"drugbank":["DB15123"]},"linkedTargets":{"rows":["ENSG00000106633"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0009878"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297565","drugType":"Antibody","blackBoxWarning":false,"name":"CERTOLIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Certolizumab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297631","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)NCCCCOn1c(CCCC)nc2c(N)nc3ccccc3c21","inchiKey":"RRTPWQXEERTRRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELRATOLIMOD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3M-052","MEDI9197","Medi 9197","Medi-9197","Medi9197","Telratolimod"],"linkedTargets":{"rows":["ENSG00000101916","ENSG00000196664"],"count":2},"linkedDiseases":{"rows":["EFO_0000764","EFO_0002913"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297684","drugType":"Protein","blackBoxWarning":false,"name":"ABICIPAR PEGOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-150998","Abicipar pegol","Agn-150998","MP-0112","MP-0260","MP0112","Mp0112","P7FHD7AG35","Vegf-a binding darpin"],"linkedTargets":{"rows":["ENSG00000112715"],"count":1},"linkedDiseases":{"rows":["EFO_0009606","MONDO_0003005","EFO_0001365","EFO_0005753","EFO_0009321"],"count":5},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297697","drugType":"Unknown","blackBoxWarning":false,"name":"AVI-7288","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avi-7288"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297717","drugType":"Unknown","blackBoxWarning":false,"name":"CD24FC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cd24fc","Cd24igg1fc","Efprezimod alfa","MK-7110","Saccovid"],"linkedTargets":{"rows":["ENSG00000080824","ENSG00000204388","ENSG00000204389","ENSG00000189403","ENSG00000142512","ENSG00000096384"],"count":6},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0100096","EFO_0002617"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297805","drugType":"Unknown","blackBoxWarning":false,"name":"PF-06671008","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06671008","Pf-06671008"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297848","drugType":"Antibody","blackBoxWarning":false,"name":"VOFATAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-FGR3","B-701","MFGR-1877A","MFGR-1877S","MFGR1877A","MFGR1877S","Mfgr1877s","Vofatamab"],"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298081","drugType":"Unknown","blackBoxWarning":false,"name":"HEPATOPOIETIN-A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hepatocyte growth factor","Hepatopoietin-a","Recombinant human hepatocyte growth factor"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4300557","canonicalSmiles":"CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC","inchiKey":"VFUXSYAXEKYYMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KW-2478","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297298"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL443030","canonicalSmiles":"COc1cc(CN2C(=O)N(Cc3ccc(O)c(OC)c3)N(Cc3ccccc3)C[C@@H](O)[C@H]2Cc2ccccc2)ccc1O","inchiKey":"PMBZSBGCSQGJAQ-GRKNLSHJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL443030","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02804"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594246","canonicalSmiles":"CCC(CC)C(=O)OCOC(=O)C1=C(S[C@H]2CC[S+]([O-])C2)S[C@@H]2[C@@H]([C@@H](C)O)C(=O)N12","inchiKey":"NBPVNGWRLGHULH-JKOUTOBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULOPENEM ETZADROXIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-03709270","PF03709270","Sulopenem etzadroxil"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594434","canonicalSmiles":"C[C@H](NC(=O)/C(C#N)=C/C=C/c1cccc(Br)n1)c1ccccc1","inchiKey":"IVAUEQVCSQZMGV-QIUCFAMLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOL-4239","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MOL-4239","MOL4239","Mol-4239","Mol4239","WP-1220","WP1220"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594483","drugType":"Unknown","blackBoxWarning":false,"name":"NY-ESO-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eso-1","L antigen family member 2","Lage-2","NY-ESO-1","Ny-eso-1","Ny-eso-1(157-170)"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL464792","canonicalSmiles":"CC(/C=C/C=C(\\C)C(=O)O)=C\\C=C\\C=C(C)\\C=C\\C=C(/C)C(=O)O","inchiKey":"PANKHBYNKQNAHN-MQQNZMFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANSCROCETIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8,8-diapocarotenedioic acid","CI-75100","Ci 75100","Crocetin","LEAF-4L6715","Leaf-4l7520","NSC-407300","Trans-crocetin","Transcrocetin","Transcrocetinate","Transcrocetinic acid"],"crossReferences":{"Wikipedia":["Crocetin"],"drugbank":["DB05974"],"chEBI":["3918"]},"childChemblIds":["CHEMBL3137335"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4650280","canonicalSmiles":"Cc1cnc(NC2CCOCC2)nc1-n1cnc(C(=O)N[C@H](CN)c2cc(F)cc(Cl)c2)c1","inchiKey":"PWHIUQBBGPGFFV-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASN007","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASN007","Asn007","Asn007 rd"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802150","canonicalSmiles":"Nc1cc(S(=O)(=O)c2ccc(OC(F)(F)F)cc2)cnc1-c1nnc(CO)o1","inchiKey":"WOXOLLSAICIZNO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAVOCAFTOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-3067","Abbv-3067","GLPG-3067","GLPG3067","Navocaftor"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL49642","canonicalSmiles":"O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12","inchiKey":"SOLIIYNRSAWTSQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIBULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-24851","Indibulin","ZIO-301"],"crossReferences":{"PubChem":["174007308"],"drugbank":["DB06169"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL501680","canonicalSmiles":"C=CC1=C(C)/C(=C/c2[nH]c(Cc3[nH]c(/C=C4\\NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)O)c(CCC(=O)O)c2C)NC1=O","inchiKey":"BPYKTIZUTYGOLE-IFADSCNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BILIRUBIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(4z,15z)-bilirubin ix.alpha.","Bilirubin","Bilirubin ix.alpha.","Bilirubin test","Cholerythrin","Hematoidin","NSC-26685"],"crossReferences":{"PubChem":["26749657"],"Wikipedia":["Bilirubin"],"chEBI":["16990"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL514","canonicalSmiles":"O=NN(CCCl)C(=O)NC1CCCCC1","inchiKey":"GQYIWUVLTXOXAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOMUSTINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ccnu","Ceenu","Gleostine"],"synonyms":["CCN-U","CCNU","Lomustine","NSC-79037"],"crossReferences":{"DailyMed":["lomustine"],"PubChem":["119147","144206023","170464967","174007397","50112720"],"TG-GATEs":["49"],"Wikipedia":["Lomustine"],"drugbank":["DB01206"],"chEBI":["6520"]},"childChemblIds":["CHEMBL3250425","CHEMBL3250423","CHEMBL3250424"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 4 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL514446","canonicalSmiles":"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC(=O)[C@@]21C","inchiKey":"OHXPGWPVLFPUSM-KLRNGDHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEHYDROCHOLIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decholin","Dilabil","Procholon"],"synonyms":["Dehydrocholic acid","NSC-8796"],"crossReferences":{"PubChem":["144205072","170465502","56422207","855992"],"Wikipedia":["Dehydrocholic_acid"],"drugbank":["DB11622"],"chEBI":["31459"]},"childChemblIds":["CHEMBL2106184"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL54","canonicalSmiles":"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1","inchiKey":"LNEPOXFFQSENCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HALOPERIDOL","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dolpin","Dozic","Fortunan","Haldol","Haldol solutab","Haloperidol","Kentace","Keselen","Serenace"],"synonyms":["Haloperidol","Haloperidol decanoate impurity, haloperidol-","MCN-JR-1625","NSC-170973","NSC-615296","R-1625"],"crossReferences":{"DailyMed":["haloperidol","haloperidol%20lactate"],"PubChem":["104171168","11111260","11112116","11113356","124880286","124880288","124880291","124880292","144203713","144210793","170464841","26747061","26747062","26751574","26751575","487337","50100251","50104201","50104202","56422397","85231072","855969","90341418"],"TG-GATEs":["36"],"Wikipedia":["Haloperidol"],"drugbank":["DB00502"],"chEBI":["5613"]},"childChemblIds":["CHEMBL2096643","CHEMBL4297147","CHEMBL1160253","CHEMBL545608","CHEMBL2234294"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000102468","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0004216","HP_0000726","EFO_0005323","EFO_0003015","EFO_0000677","EFO_0003768","EFO_0005407","EFO_0009267","EFO_1000948","EFO_0003843","HP_0002018","HP_0000713","EFO_0007191","MONDO_0005277","Orphanet_399","EFO_0004247","EFO_0000289","MONDO_0002050","EFO_0004895","MONDO_0004975","EFO_0004888","EFO_0004701","EFO_0005230","EFO_0005411","EFO_0009954"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 5 approved and 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL590","canonicalSmiles":"CC1=CC(=O)c2ccccc2C1=O","inchiKey":"MJVAVZPDRWSRRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MENADIONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kappaxin","Kayquinone","Menadione","Vitamin K 3"],"synonyms":["1,4-naphthalenedione, 2-methyl","Menadione","Menaphthene","Menaphthone","NSC-4170","Vitamin k 3","Vitamin k3"],"crossReferences":{"PubChem":["104171275","11112142","11532917","144203885","144211684","170464997","174006181","174316135","26748651","56422378","70547"],"Wikipedia":["Menadione"],"drugbank":["DB00170"],"chEBI":["28869"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for hemorrhage."}
{"id":"CHEMBL606260","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)[O-])c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+].[Na+]","inchiKey":"RTYJTGSCYUUYAL-YCAHSCEMSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN DISODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1214","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Geopen","Pyopen"],"synonyms":["BRL-2064","CP-15-639-2","Carbenicillin disodium","Carbenicillin disodium salt","Carbenicillin sodium","NSC-111071"],"crossReferences":{"PubChem":["144204857","170465106","855754"],"chEBI":["34609"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL609147","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2ccccc2)CC1","inchiKey":"GARXJOUQUSNOGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-30490","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-30490"],"crossReferences":{"Wikipedia":["R-30490"],"drugbank":["DB09179"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL727","canonicalSmiles":"Nc1nc2[nH]cnc2c(=S)[nH]1","inchiKey":"WYWHKKSPHMUBEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOGUANINE","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lanvis","Tabloid","Thioguanine"],"synonyms":["NSC-752","NSC-76504","Thioguanine","Thioguanine anhydrous","Thioguanine hemihydrate","Thioguanine, anhydrous","Tioguanine","Tioguanine hemihydrate"],"crossReferences":{"PubChem":["144204586","144206735","144209599","144210595","170464908","174007001","26748270","538243","57260104","57264437"],"Wikipedia":["Tioguanine"],"drugbank":["DB00352"],"chEBI":["9555"]},"linkedTargets":{"rows":["ENSG00000106348","ENSG00000178035"],"count":2},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0003812","EFO_1001945","EFO_0000209","EFO_0005952","MONDO_0003541","EFO_0000565","EFO_0004251","EFO_1000318","EFO_1001935","EFO_0004289","MONDO_0001657","EFO_0000330","MONDO_0020743","EFO_0000183","EFO_0000198","EFO_0000221","EFO_0000616","EFO_0003802","EFO_1001779","EFO_0000220","MONDO_0019457","EFO_0000222","EFO_0000223","EFO_1001946","MONDO_0000870","EFO_0003029","EFO_0003025","MONDO_0044917","EFO_1001936","EFO_0000574","EFO_1001947","EFO_0000218","MONDO_0024880","EFO_0003833","EFO_0000519","MONDO_0021640","EFO_0003811","EFO_0003027"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and is indicated for neoplasm and has 26 investigational indications."}
{"id":"CHEMBL7983","canonicalSmiles":"CCCOC(=O)c1cc(O)c(O)c(O)c1","inchiKey":"ZTHYODDOHIVTJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPYL GALLATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anhydrous propyl gallate (e 310)","E-310","E310","FEMA NO. 2947","Gallic acid, propyl ester","INS NO.310","INS-310","NSC-2626","Propyl gallate","Propyl gallate (e 310)"],"crossReferences":{"PubChem":["144207080","144209484","144210380","225144253","26757651","69249"],"Wikipedia":["Propyl_gallate"],"drugbank":["DB12450"],"chEBI":["10607"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL838","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O","inchiKey":"XPCFTKFZXHTYIP-PMACEKPBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BENAZEPRIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benazepril","Benazepril sandoz","Briem","C09AA07","CGS-14824A","Cibacen ws","Cibacene","Forteekor","Lotensin","Lotrel"],"crossReferences":{"DailyMed":["benazepril%20hydrochloride"],"Wikipedia":["Benazepril"],"drugbank":["DB00542"],"chEBI":["3011"]},"childChemblIds":["CHEMBL1694"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0003124","EFO_1000965","EFO_0001645","EFO_0000319","EFO_1002048","EFO_0000537","Orphanet_63","EFO_0003914","Orphanet_79292","EFO_0002690","EFO_0000712","EFO_0004285","EFO_0000400","Orphanet_88917","MONDO_0005148","EFO_0000407"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 5 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
